Raye Z. Litten

2.9k total citations · 1 hit paper
26 papers, 2.1k citations indexed

About

Raye Z. Litten is a scholar working on Epidemiology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Raye Z. Litten has authored 26 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 14 papers in Pathology and Forensic Medicine and 6 papers in Molecular Biology. Recurrent topics in Raye Z. Litten's work include Substance Abuse Treatment and Outcomes (15 papers), Alcohol Consumption and Health Effects (14 papers) and Muscle Physiology and Disorders (4 papers). Raye Z. Litten is often cited by papers focused on Substance Abuse Treatment and Outcomes (15 papers), Alcohol Consumption and Health Effects (14 papers) and Muscle Physiology and Disorders (4 papers). Raye Z. Litten collaborates with scholars based in United States, Germany and United Kingdom. Raye Z. Litten's co-authors include John P. Allen, Joanne B. Fertig, Thomas F. Babor, Raymond F. Anton, Norman R. Alpert, John P. Allen, Henry R. Kranzler, Daniel E. Falk, Katie Witkiewitz and R B Low and has published in prestigious journals such as Circulation Research, The American Journal of Cardiology and American Journal of Physiology-Heart and Circulatory Physiology.

In The Last Decade

Raye Z. Litten

26 papers receiving 2.0k citations

Hit Papers

A Review of Research on the Alcohol Use Disorders Identif... 1997 2026 2006 2016 1997 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raye Z. Litten United States 20 1.1k 724 403 308 253 26 2.1k
Amy Z. Fan United States 22 936 0.8× 551 0.8× 406 1.0× 248 0.8× 231 0.9× 42 2.1k
Joseph S. LoCastro United States 19 1.3k 1.1× 619 0.9× 378 0.9× 370 1.2× 68 0.3× 29 2.3k
Michael J. Bohn United States 16 1.2k 1.0× 449 0.6× 396 1.0× 485 1.6× 96 0.4× 21 2.5k
Chiung M. Chen United States 23 1.0k 0.9× 550 0.8× 362 0.9× 413 1.3× 53 0.2× 34 2.0k
Michael Soyka Germany 28 1.3k 1.1× 510 0.7× 262 0.7× 565 1.8× 48 0.2× 136 3.1k
Richard K. Fuller United States 23 1.4k 1.2× 810 1.1× 324 0.8× 263 0.9× 37 0.1× 43 2.5k
Jonathan Chick United Kingdom 29 1.9k 1.7× 1.2k 1.7× 607 1.5× 586 1.9× 51 0.2× 102 3.4k
Linda Gowing Australia 29 1.5k 1.4× 157 0.2× 324 0.8× 357 1.2× 64 0.3× 50 3.4k
John P. Allen United States 8 684 0.6× 413 0.6× 339 0.8× 277 0.9× 55 0.2× 9 1.2k
Xiaowei Yang United States 20 498 0.4× 239 0.3× 237 0.6× 388 1.3× 62 0.2× 27 1.7k

Countries citing papers authored by Raye Z. Litten

Since Specialization
Citations

This map shows the geographic impact of Raye Z. Litten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raye Z. Litten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raye Z. Litten more than expected).

Fields of papers citing papers by Raye Z. Litten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raye Z. Litten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raye Z. Litten. The network helps show where Raye Z. Litten may publish in the future.

Co-authorship network of co-authors of Raye Z. Litten

This figure shows the co-authorship network connecting the top 25 collaborators of Raye Z. Litten. A scholar is included among the top collaborators of Raye Z. Litten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raye Z. Litten. Raye Z. Litten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Knox, Justin, Jennifer Scodes, Melanie M. Wall, et al.. (2019). Reduction in non-abstinent WHO drinking risk levels and depression/anxiety disorders: 3-year follow-up results in the US general population. Drug and Alcohol Dependence. 197. 228–235. 40 indexed citations
3.
Witkiewitz, Katie, Daniel E. Falk, Raye Z. Litten, et al.. (2019). Maintenance of World Health Organization Risk Drinking Level Reductions and Posttreatment Functioning Following a Large Alcohol Use Disorder Clinical Trial. Alcoholism Clinical and Experimental Research. 43(5). 979–987. 43 indexed citations
4.
Knox, Justin, Melanie M. Wall, Katie Witkiewitz, et al.. (2018). Reduction in Nonabstinent WHO Drinking Risk Levels and Change in Risk for Liver Disease and Positive AUDIT‐C Scores: Prospective 3‐Year Follow‐Up Results in the U.S. General Population. Alcoholism Clinical and Experimental Research. 42(11). 2256–2265. 51 indexed citations
5.
Witkiewitz, Katie, Henry R. Kranzler, Kevin A. Hallgren, et al.. (2018). Drinking Risk Level Reductions Associated with Improvements in Physical Health and Quality of Life Among Individuals with Alcohol Use Disorder. Alcoholism Clinical and Experimental Research. 42(12). 2453–2465. 88 indexed citations
6.
Witkiewitz, Katie, Adam D. Wilson, Matthew R. Pearson, et al.. (2017). Temporal Stability of Heavy Drinking Days and Drinking Reductions Among Heavy Drinkers in the COMBINE Study. Alcoholism Clinical and Experimental Research. 41(5). 1054–1062. 26 indexed citations
7.
Witkiewitz, Katie, Kevin A. Hallgren, Henry R. Kranzler, et al.. (2016). Clinical Validation of Reduced Alcohol Consumption After Treatment for Alcohol Dependence Using the World Health Organization Risk Drinking Levels. Alcoholism Clinical and Experimental Research. 41(1). 179–186. 110 indexed citations
8.
Witkiewitz, Katie, Daniel E. Falk, Henry R. Kranzler, et al.. (2014). Methods to Analyze Treatment Effects in the Presence of Missing Data for a Continuous Heavy Drinking Outcome Measure When Participants Drop Out from Treatment in Alcohol Clinical Trials. Alcoholism Clinical and Experimental Research. 38(11). 2826–2834. 50 indexed citations
9.
Allen, John P., et al.. (2001). The Role of Biomarkers in Alcoholism Medication Trials. Alcoholism Clinical and Experimental Research. 25(8). 1119–1125. 2 indexed citations
10.
Litten, Raye Z. & J.P. Allen. (1998). Pharmacologic treatment of alcoholics with collateral depression: issues and future directions.. PubMed. 34(1). 107–10. 10 indexed citations
11.
Allen, John P., Raye Z. Litten, Joanne B. Fertig, & Thomas F. Babor. (1997). A Review of Research on the Alcohol Use Disorders Identification Test (AUDIT). Alcoholism Clinical and Experimental Research. 21(4). 613–619. 768 indexed citations breakdown →
12.
O’Farrell, Timothy J., John P. Allen, & Raye Z. Litten. (1995). Disulfiram (Antabuse) Contracts in Treatment of Alcoholism. PsycEXTRA Dataset. 150. 65–91. 26 indexed citations
13.
Allen, John P., Raye Z. Litten, Raymond F. Anton, & Gerald M. Cross. (1994). Carbohydrate‐Deficient Transferrin as a Measure of Immoderate Drinking: Remaining Issues. Alcoholism Clinical and Experimental Research. 18(4). 799–812. 154 indexed citations
14.
Litten, Raye Z. & John P. Allen. (1991). Pharmacotherapies for Alcoholism: Promising Agents and Clinical Issues. Alcoholism Clinical and Experimental Research. 15(4). 620–633. 85 indexed citations
15.
Litten, Raye Z., et al.. (1990). Alterations in rat cardiac myosin isozymes induced by whole-body irradiation are prevented by 3,5,3′-l-triiodothyronine. Metabolism. 39(1). 64–68. 4 indexed citations
16.
Litten, Raye Z., et al.. (1989). Alteration of cardiac myosin isozymes after whole-body irradiation. British Journal of Radiology. 62(734). 189–191. 1 indexed citations
17.
Nagai, R, R B Low, William S. Stirewalt, Norman R. Alpert, & Raye Z. Litten. (1988). Efficiency and capacity of protein synthesis are increased in pressure overload cardiac hypertrophy. American Journal of Physiology-Heart and Circulatory Physiology. 255(2). H325–H328. 36 indexed citations
18.
Litten, Raye Z., Barbara J. Martin, R B Low, & Norman R. Alpert. (1982). Altered myosin isozyme patterns from pressure-overloaded and thyrotoxic hypertrophied rabbit hearts.. Circulation Research. 50(6). 856–864. 167 indexed citations
19.
Litten, Raye Z., et al.. (1981). Phosphorylation and adenosine triphosphatase activity of myofibrils from thyrotoxic rabbit hearts.. Circulation Research. 48(4). 498–501. 26 indexed citations
20.
Alpert, Norman R., L. A. Mulieri, & Raye Z. Litten. (1979). Functional significance of altered myosin adenosine triphosphatase activity in enlarged hearts. The American Journal of Cardiology. 44(5). 947–953. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026